Pharmafile Logo

Trends in the Pharma Industry – A Lucid Thirsty Thursday Session

- PMLiVE

Rob Apollo, Corporate Development Director of Lucid Group, kicked off the first of a series of Thirsty Thursday sessions with a thought-provoking discussion around trends in the pharma industry and the future of MedComms.

Lucid loves to push the boundaries of the pharma industry, continually challenging the status quo by constantly innovating for its clients and, ultimately, for patients. However, in order to do this, it’s imperative to look to the future and predict industry trends. To stimulate discussion, Rob opened the session by asking the audience what they thought the future holds for the pharma industry.

This highly interactive session touched on notable themes raised at the eyeforpharma conference earlier this year. Discussions were sparked around the changing way the world communicates and how information is consumed; how personalised medicine will impact the industry and where pharma sits in the world of big data. Everyone engaged with the discussion, assessing past and future trends, before considering the impact on MedComms and the importance of being able to evolve and transform as an organisation in line with the changing environment.

Lucid’s Thirsty Thursday sessions reflects its pioneering and human-centric spirit. By constantly up-skilling the team and providing a dynamic learning environment, they can foster innovation and create the magic needed to improve outcomes and transform lives.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences

Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid...

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Meet The Lucid Group Talent Team

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...